SABER .035 Percutaneous Transluminal Angioplasty (PTA) Dilatation Catheter— 510(k) K210626

Substantially Equivalent

Cordis Corporation

FDA 510(k) clearance K210626 for SABER .035 Percutaneous Transluminal Angioplasty (PTA) Dilatation Catheter, Substantially Equivalent on 2021-04-23. Applicant: Cordis Corporation.

Clearance details

Applicant: Cordis Corporation
Product code: Code LIT
Advisory panel: Cardiovascular
Date received: 2021-03-02
Decision date: 2021-04-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami Lakes, FL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LIT

product code LIT

Death: 27
Injury: 1,256
Malfunction: 12,127
Total: 13,410

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.